Virpax Pharmaceuticals, Inc. (VRPX)
VRPX Stock Price Chart
Explore Virpax Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze VRPX price movements and trends.
VRPX Company Profile
Discover essential business fundamentals and corporate details for Virpax Pharmaceuticals, Inc. (VRPX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Feb 2021
Employees
2.00
Website
https://www.virpaxpharma.comCEO
Jatinder Dhaliwal
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
VRPX Financial Timeline
Browse a chronological timeline of Virpax Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 12 May 2025
EPS came in at -$68.75 .
Stock split effective on 21 Mar 2025
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Mar 2025
EPS came in at -$0.80 falling short of the estimated -$0.27 by -196.30%.
Earnings released on 14 Nov 2024
EPS came in at -$10.75 falling short of the estimated -$0.54 by -1.89K%.
Earnings released on 12 Aug 2024
EPS came in at -$43.75 falling short of the estimated -$1.53 by -2.76K%.
Earnings released on 13 May 2024
EPS came in at -$68.75 .
Earnings released on 26 Mar 2024
EPS came in at -$3.90 falling short of the estimated -$2.70 by -44.44%.
Stock split effective on 1 Mar 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2023
EPS came in at -$127.50 falling short of the estimated -$0.26 by -48.94K%.
Earnings released on 14 Aug 2023
EPS came in at -$67.50 falling short of the estimated -$40.00 by -68.75%.
Earnings released on 12 May 2023
EPS came in at -$32.50 surpassing the estimated -$75.00 by +56.67%.
Earnings released on 22 Mar 2023
EPS came in at -$65.00 falling short of the estimated -$6.70 by -870.15%.
Earnings released on 9 Nov 2022
EPS came in at -$162.50 falling short of the estimated -$0.45 by -36.01K%.
Earnings released on 15 Aug 2022
EPS came in at -$125.00 falling short of the estimated -$0.44 by -28.31K%.
Earnings released on 16 May 2022
EPS came in at -$110.00 .
Earnings released on 31 Mar 2022
EPS came in at -$0.62 surpassing the estimated -$3.40 by +81.86%.
Earnings released on 15 Nov 2021
EPS came in at -$132.50 .
Earnings released on 10 Aug 2021
EPS came in at -$117.50 .
Earnings released on 18 May 2021
EPS came in at -$0.60 falling short of the estimated -$0.54 by -11.68%.
Earnings released on 31 Mar 2021
EPS came in at -$0.16 .
Earnings released on 30 Sept 2020
EPS came in at -$0.38 .
VRPX Stock Performance
Access detailed VRPX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.